133 results on '"de Souza, Carmino A."'
Search Results
2. Correction of Intensity of Bone Involvement (IBI) Index by Lean Body Mass and Body Surface Area
3. Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
4. CML-425 Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients – A Real-World Study
5. POSTER: CML-425 Evaluation of Antibody Responses among Five Different SARS-Cov-2 Vaccines in Chronic Myeloid Leukemia (CML) Patients – A Real-World Study
6. P1199: CLINICAL UPSHOTS OF PIONEER PROJECT TO COLLECT DATA OF T-CELL NHL PATIENTS AMONG FIVE REGIONS OF BRAZIL. T-CELL BRAZIL PROJECT.
7. PB1977: EVALUATION OF ANTIBODY RESPONSES AMONG FIVE DIFFERENT SARS-COV-2 VACCINES IN CHRONIC MYELOID LEUKEMIA PATIENTS – A REAL-WORLD STUDY
8. Treatment patterns and outcomes for Hodgkin Lymphoma patients aged 60 and older: a report from the Brazilian Prospective Hodgkin Lymphoma Registry
9. T084: Treatment patterns and outcomes for Hodgkin’s Lymphoma (HL) patients (pts) aged 60 and older: a report from the Brazilian Prospective Hodgkin’s lymphoma Registry
10. P018: Treatment outcomes in classical Hodgkin lymphoma (HL): 5-year update report from the Brazilian Prospective Registry
11. HOW I TREAT DOUBLE-HIT LYMPHMOMA AND HGBL, NOS
12. AN UPDATED OF PIONEER PROJECT TO COLLECT DATA OF T-CELL NHL PATIENTS AMONG FIVE REGIONS OF BRAZIL. T-CELL BRAZIL PROJECT
13. Characteristics and clinical outcomes of patients with ALK‐positive anaplastic large cell lymphoma: Report from the prospective international T‐cell lymphoma project
14. Metabolic Volume Measurements in Multiple Myeloma
15. CURRENT THERAPY FOR INDOLENT LYMPHOMAS
16. Effects of a physiotherapeutic protocol in cardiorespiratory, muscle strength, aerobic capacity and quality of life after hematopoietic stem cell transplantation
17. Head-to-head comparison between 68Ga-PSMA and 18F-FDG-PET/CT in lymphomas: a preliminary analysis
18. Peripheral oxygen measurements in suspected elderly COVID-19 patients can be an effective tool for alerting physicians
19. COVID-19 in chronic myeloid leukemia patients in Latin America
20. The Brazilian Association of Hematology, Hemotherapy and Cellular Therapy seeks the implementation of, and access to, the CAR-T cell treatment in Brazil
21. How’s going on the T-Cell Brazil project
22. ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
23. Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial ( EDI‐PIO ) in chronic myeloid leukemia with deep molecular response
24. 99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma
25. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
26. Impact of SNPs/Haplotypes of IL10 and IFNG on the Development of Diffuse Large B-Cell Lymphoma
27. Proposal for a Quantitative 18F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma
28. How I treat relapsed/refractory DLBCL patients
29. Increased risk of Hodgkin lymphoma in males with inherited T lymphocyte receptor programed death-1 deficiency
30. Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
31. B3a2 Transcript Is an Independent Factor for the Achievement of a Deep Molecular Response in Chronic Phase - Chronic Myeloid Leukemia Patients Treated with Imatinib in First-Line
32. Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study
33. Angiogenesis’ Related Polymorphism Emerges as Prognostic Marker in De Novo Large B-Cell Lymphoma Patients
34. Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population
35. T cell Brazil project: A pioneer project to collect data of T-Cell NHL patients among five regions of Brazil
36. Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
37. Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry
38. Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry
39. Phase II trial of dasatinib (DAS) in pediatric patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP).
40. VEGF, VEGFR2 and GSTM1 polymorphisms in Outcome of Multiple Myeloma Patients in the Thalidomide Era
41. Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg
42. Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial
43. Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies
44. VEGF, VEGFR2 and GSTM1 Polymorphisms in Outcome of Multiple Myeloma Patients in the Thalidomide Era
45. Pretransplant β 2 -Microglobulin Is Associated with the Risk of Acute Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant
46. Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients
47. Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
48. Polymorphisms in key regulator genes of the intrinsic apoptosis pathway in risk and clinical presentation of diffuse large B‐cell lymphoma
49. Pre-Transplant Beta2-Microglobulin Is an Independent Biomarker of Acute Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant in a Single Institutional Study
50. Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.